Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69.
Published June 18, 2014 · Recall initiated: March 26, 2014
Summary
FDA records drug Class I recall D-1362-2014, published June 18, 2014 and initiated March 26, 2014. Recalling firm: Pharmakon Pharmaceuticals; Status: Terminated; Reported quantity: 80 syringes; Lot: Lot #: E1016227C, Exp. 4/21/2014; E0433735C, Exp. 4/20/2014. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug: Product contains twice the stated amount of midazolam.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pharmakon Pharmaceuticals
- Distributor
- IN
- Lot
- Lot #: E1016227C, Exp. 4/21/2014; E0433735C, Exp. 4/20/2014
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAKetamine 50 mg/mL, injectable packed in syringes, Total dosage 50 mg/ 1mL, Rx only, PHARMAKON Pharmaceuticals,February 3, 2016
- FDAEphedrine Sulfate 5 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 25 mg/ 5mL, RxFebruary 3, 2016
- FDAProvocholine Pre-diluted Set II in 0.9% Sodium Chloride, 0.0625 mg/mL, 3 mL in 5 mL Syr, injectable packed inFebruary 3, 2016
- FDAPhenylephrine (PF) 100 mcg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 500 mcg/February 3, 2016
- FDAVenlafaxine HCl Extended-Release Capsules, 150 mg, 90-count Unit of Use bottles, Rx only, Distributed by:June 18, 2014
- FDAPantoprazole Sodium, Delayed-release tablets, USP, 40 mg tablets, 100 (10x10) unit dose packages, ManufacturedJune 18, 2014
Questions about this recall
Was Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69. recalled?
Yes. FDA published recall D-1362-2014 on June 18, 2014. Reported hazard: Superpotent Drug: Product contains twice the stated amount of midazolam.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone